August 26, 2019 by Steve Blade
ENT Surgical Devices Market Overview, ENT Surgical Devices Market Trends, ENT Surgical Devices Market report, ENT Surgical Devices Market Share, ENT Surgical Devices Market Report, ENT Surgical Devices Market
According to Fact.MR study, the ENT endoscopes are estimated to account for over half the revenues of the ENT diagnostic devices market in 2019. Endoscopy has played a significant role in the diagnosis of ear, nose and throat related diseases as well as successful treatment outcomes. Owing to this, ENT endoscopes have become the most common devices in the ENT clinics.
Fact.MR estimates that powered ENT surgical system will also register considerable demand in 2019. Powered ENT instruments are used in procedures such as removal of soft tissue, hard tissue and bone during surgery. On the other hand, the ENT visualization systems are growing at a faster pace and over 9% y-o-y growth is expected in 2019.
Table of Content
1. Executive Summary
2. Market Introduction
3. ENT Surgical Devices Market Overview
4. Market Dynamics
5. Key Inclusions
To be Continue............
ENT Surgical Devices Market Structure
The ENT surgical devices market study is based on a comprehensive analysis of the demand-supply scenario of all the important market facets. Thus derived structure of the ENT surgical devices market is segmented based on product type, modality and end users.
Based on product type, the ENT surgical devices market is sub-segmented into a number of devices such as hand instrument, ENT surgical lasers, powered ENT surgical systems, electrosurgical and radiofrequency devices, ENT surgery workstations, ENT surgical navigation system, ENT visualization system and surgical microscopes.
On the basis of modality, the ENT surgical devices market is sub-segmented into hand-held devices, portable devices and fixed devices. End-user segment of the ENT surgical devices includes hospitals, ambulatory surgical centers and ENT clinics.
Minimally Invasive Surgeries – A Trending Approach in ENT Surgical Devices Market
Minimally invasive surgeries continue to gain momentum in the healthcare owing to associated benefits as compared to the traditional surgical approach. While the traditional approach continues to remain in the mainstream, the minimal invasion has replaced the traditional approach to a greater extent. Growing preference for minimal invasion has led manufacturers to introduce devices to perform ENT surgeries with minimal invasion.
Current ENT procedures such as septoplasty, laryngeal surgery, trans-oral robotic surgery, tonsillectomy, and endoscopic sinus surgery are performed using minimal invasion approach. A considerable amount of R&D investments are involved to combine robotics technology with minimal invasion procedures and develop ENT surgical devices with enhanced surgical efficiency.
ENT Surgical Devices Market - Competitive Landscape
The ENT surgical devices market report covers information on the competitive landscape that delivers the competition scenario and future opportunities in the ENT surgical devices marketplace. Readers can find a dashboard view of key players and a company profile section which provides information regarding product offerings, new introductions, market presence, global footprint and notable developments of key players in the ENT surgical devices market.
Few of the profiled players in the ENT surgical devices market include Olympus Corporation, Medtronic PLC, Carl Zeiss Meditec AG, 16.4.Danaher Corporation (Leica Microsystems), Shanghai Fosun Pharmaceuticals Ltd. (AC. Alma Lasers), KLS Martin LP, Acclarent, Inc., Smith and Nephew PLC, ClaroNav, Collin SAS, Lumenis and Brainlab.
Major investments in the ENT surgical devices market are in clinical research studies that are aimed at receiving authorization. The ENT surgical devices marketplace has witnessed a number of FDA clearance in past few years.
In October 2018, Carl Zeiss Meditech AG announced the launch of TIVATO 700 and EXTARO 300 microscopes with improved visualization and enhanced workflow augmentation concept based on an all-digital approach for ENT procedures.
In March 2018, Olympus Corporation launched ENF-VT3, the world’s first rhino-laryngo videoscope with an aim to incorporate 4-direction angulation capability.
In December 2017, Intersect ENT announced FDA approval of a new sinus implant SINUVATM which is an in-office treatment option for recurrent nasal polyps.
For More information Raise Enquiry
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852